Sign in

NCT07043166Recruiting

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

Epidemiological Survey and Follow-up of Cardiovascular-Kidney-Metabolic Diseases Among Adults in Shanghai

Source: ClinicalTrials.gov · Last updated 8 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The main purpose of this study is to conduct follow-up assessments and update the cardiorenal outcomes among the STONE cohort that was established during 2016-2017. The secondary aim is to compare metabolic risk factors, metabolic disturbances, and clinically relevant metabolic outcomes between the follow-up period and the baseline assessment. The exploratory goal is to examine the relationships between changes in risk factors and clinical outcomes in the participants. The study is planned to begin in May 2025 and will finalize the data collection for the entire population by June 2026. During this time, participants will be categorized based on CKM staging. The follow-up phase will continue until 2035.

Status (registry)
Recruiting
Study type
Observational
Enrollment
4094 (estimated)
First submitted
14 Jun 2025
Start date
1 Jul 2025
Primary completion date
30 May 2035
Lead sponsor
Shanghai Changzheng Hospital
NCT number
NCT07043166

What you commit to

  • Study type: Observational
  • Planned participants: 4094
  • From 1 Jul 2025 to the primary completion date, 30 May 2035
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participants who have moved away from their original community and have been living elsewhere for more than two years.
  • Participants whose contact information has changed or become invalid, resulting in loss of contact (those who remain uncontactable after three attempts to reach out).

Who the study is looking for

  • The 4,094 residents of Shanghai communities who have been enrolled in the STONE cohort.
  • Individuals who completed the baseline questionnaire survey, physical examination, and related clinical tests between 2016 and 2017, with complete data records.
  • Willingness to participate in this follow-up study and provision of informed consent.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shanghai Changzheng Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.